Myelodysplastic Syndromes : Diagnosis - Prognosis - Therapy. [electronic resource]

Autor: Platzbecker, Uwe

Externí odkaz: Kolekce e-knih KNAV Registrovani uzivatele: plny text online 5 minut, dalsi pristup na vyzadani. Registered users: full text online 5 minutes, further access on requests.

Integration of the Ki-67 proliferation index into the Ogata score improves its diagnostic sensitivity for low-grade myelodysplastic syndromes

Autor: Stefan G.C. Mestrum, Eline M.P. Cremers, Norbert C.J. de Wit, Roosmarie J.M. Drent, Frans C.S. Ramaekers, Anton H.N. Hopman, Math P.G. Leers

Publikováno v: Leukemia Research, 113
Leukemia Research, 113:106789. Elsevier Limited

Contains fulltext : 251730.pdf (Publisher’s version ) (Open Access) BACKGROUND: Although flow cytometric detection of myelodysplastic syndrome (MDS) with the Ogata score has a high specificity, its sensitivity for low-grade MDS is low. Additional m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad6aadf1b4272ed517c87a67ed33f3d1
https://doi.org/10.1016/j.leukres.2022.106789

Germ line predisposition for myeloid neoplasia in adults

Autor: Nitschke, Nikolaj Juul, Andersen, Mette Klarskov, Grønbæk, Kirsten

Publikováno v: Nitschke, N J, Andersen, M K & Grønbæk, K 2021, ' Arvelig prædisposition til myeloid neoplasi hos voksne ', Ugeskrift for Laeger, bind 183, nr. 42, V04210346 . < https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2021-10/v04210346_web.pdf >

I lang tid har opfattelsen været, at myeloid neoplasi (MN) opstår sporadisk med ukendt ætiologi, fraset udvikling af myelodysplastisk syndrom (MDS) og akut myeloid leukæmi (AML) efter kemo-/stråleterapi. I takt med den hastige udvikling af next

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2751::45d9ab75ae7403f264af8ed7002933ee
https://curis.ku.dk/ws/files/337985739/v04210346_web.pdf

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS

Autor: Carme Pedro, Heinz Sill, Michael Lübbert, Mario Cazzola, A.A. van de Loosdrecht, Heinz Tuechler, Javier Grau, Hartmut Döhner, Michael Pfeilstöcker, Alan F. List, A.A.N. Giagounidis, Peter L. Greenberg, M.G. Della Porta, Francesc Cobo, F. Solé, Gail J. Roboz, Guillermo Sanz, Sabine Blum, M. Martinez-de-Sola, Barbara Hildebrandt, Ulrich Germing, Detlef Haase, Amy E. DeZern, Rainer Haas, David P. Steensma, Richard F. Schlenk, M. Nomdedeu, Dolors Costa, María Díez-Campelo, Mikkael A. Sekeres, Christina Ganster, Rami S. Komrokji, Itziar Oiartzabal, Benet Nomdedeu, Reinhard Stauder, Arturo Pereira, Jordi Esteve, Sigrid Machherndl-Spandl, Maria Teresa Voso, Xavier Calvo, Maria-Teresa Cedena, Tobias Schroeder, Uwe Platzbecker, G. Garcia-Manero, Peter Valent, M. López-Pavía, Brayan Merchan, Blanca Xicoy, Andrea Kuendgen, Claudia D. Baldus

Publikováno v: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Leukemia
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Kuendgen, A, Nomdedeu, M, Tuechler, H, Garcia-Manero, G, Komrokji, R S, Sekeres, M A, Della Porta, M G, Cazzola, M, DeZern, A E, Roboz, G J, Steensma, D P, Van de Loosdrecht, A A, Schlenk, R F, Grau, J, Calvo, X, Blum, S, Pereira, A, Valent, P, Costa, D, Giagounidis, A, Xicoy, B, Döhner, H, Platzbecker, U, Pedro, C, Lübbert, M, Oiartzabal, I, Díez-Campelo, M, Cedena, M T, Machherndl-Spandl, S, López-Pavía, M, Baldus, C D, Martinez-de-Sola, M, Stauder, R, Merchan, B, List, A, Ganster, C, Schroeder, T, Voso, M T, Pfeilstöcker, M, Sill, H, Hildebrandt, B, Esteve, J, Nomdedeu, B, Cobo, F, Haas, R, Sole, F, Germing, U, Greenberg, P L, Haase, D & Sanz, G 2021, ' Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS ', Leukemia, vol. 35, no. 3, pp. 835-849 . https://doi.org/10.1038/s41375-020-0917-7
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Leukemia, 35(3), 835-849. Nature Publishing Group
Leukemia, vol. 35, no. 3, pp. 835-849

In the current World Health Organization (WHO)-classification, therapy-related myelodysplastic syndromes (t-MDS) are categorized together with therapy-related acute myeloid leukemia (AML) and t-myelodysplastic/myeloproliferative neoplasms into one su

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f8a5a0f2557ae57357d5b4d74c913c1
https://ddd.uab.cat/record/236625

Myelodysplastic syndrome in a patient with untreated chronic lymphoproliferative neoplasm

Autor: Ana Planinc-Peraica, Ana Reschner, Morana Kosanović-Bajić, Inga Mandac Rogulj, Gordana Kaić, Marin Kursar, Marko Martinović, Slobodanka Ostojić Kolonić, Delfa Radić-Krišto

Publikováno v: Liječnički vjesnik
Volume 141
Issue 9-10

U bolesnika s kroničnom limfoproliferativnom bolesti (LPB) veća je učestalost nastanka sekundarnih neoplazma. Istodobna pojava limfoproliferativne neoplazme (LPN) i mijelodisplastičnog sindroma (MDS) vrlo je rijetka. Druga hematološka neoplazma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______951::c895c5737778c7c751e4ec1bc513e1ae
https://hrcak.srce.hr/file/333711